BioCentury
ARTICLE | Company News

Elan, Quadrant deal

October 30, 2000 8:00 AM UTC

ELN and drug delivery company QTH agreed on terms of an offer by ELN to buy QTH for 75p per QTH share, valuing QTH at £52.3 million ($75.9 million). The move follows an earlier offer from Inhale Ther...